Report on the results of sale of securities (F53-5)
Name of Company
KIATNAKIN PHATRA SECURITIES PUBLIC COMPANY LIMITED
Date 04-Aug-2022
Maturity date
02-Aug-2022
DW symbol
Number of subscribed DW (unit)
ADVA06P2207K
0
BANP06C2207A
0
DOHO06C2207A
0
GPSC06C2207A
0
IVL06C2207K
0
KCE06P2207A
0
MEGA06C2207A
0
OSP06C2207A
0
STA06C2207A
0
VGI06C2207K
0
Signature _________________
(Supachoke Supabundit)
President
Authorized to sign on behalf of the company
This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Mega Lifesciences pcl published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2022 06:16:04 UTC.
Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.